{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "Reversing a long-held position, the Department of Veterans Affairs now says Air Force reservists who became ill after being exposed to Agent Orange residue while working on planes after the Vietnam War should be eligible for disability benefits.", "headline": {"main": "VA Moving to Extend Benefits to Some Air Force Reservists", "print_headline": "VA Moving to Extend Benefits to Some Air Force Reservists"}, "abstract": null, "print_page": null, "word_count": "800", "_id": "557c2fd67988101e22dac217", "snippet": "Reversing a long-held position, the Department of Veterans Affairs now says Air Force reservists who became ill after being exposed to Agent Orange residue while working on planes after the Vietnam War should be eligible for disability benefits.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2015/06/13/us/politics/ap-us-agent-orange.html", "multimedia": [], "subsection_name": "Politics", "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2015-06-13T09:26:14Z", "section_name": "U.S."}, {"type_of_material": "Blog", "blog": [], "news_desk": "OpEd", "lead_paragraph": null, "headline": {"main": "Death Without Dignity", "kicker": "The End", "print_headline": "Death Without Dignity"}, "abstract": "When my friend wanted to end her life, an aid-in-dying law could have helped.", "print_page": null, "word_count": "905", "_id": "5577e5dc798810054cfd03df", "snippet": "When my friend wanted to end her life, an aid-in-dying law could have helped.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://opinionator.blogs.nytimes.com/2015/06/10/death-without-dignity/", "multimedia": [{"subtype": "wide", "url": "images/2015/06/10/opinion/10Gurwitch/10Gurwitch-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/06/10/opinion/10Gurwitch/10Gurwitch-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/06/10/opinion/10Gurwitch/10Gurwitch-articleLarge.jpg", "height": 342, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/06/10/opinion/10Gurwitch/10Gurwitch-articleLarge.jpg", "xlargeheight": "342"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/06/10/opinion/10Gurwitch/10Gurwitch-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/06/10/opinion/10Gurwitch/10Gurwitch-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Death and Dying", "name": "subject", "rank": "1"}, {"value": "Law and Legislation", "name": "subject", "rank": "2"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Annabelle", "lastname": "GURWITCH"}], "original": "By ANNABELLE GURWITCH"}, "document_type": "blogpost", "pub_date": "2015-06-10T03:21:36Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Early results of clinical trials raised hopes that the therapies would be critical new additions to the treatment arsenal for those at risk of heart disease, the biggest killer of Americans.", "headline": {"main": "Federal Panel Backs Approval of New Drug to Fight Heart Attacks", "print_headline": "Drug to Fight Heart Attack Clears Panel "}, "abstract": "Expert panel recommends Food and Drug Admin approve strong new drug to protect against heart attacks; it would be first in new group of medicines that substantially lower levels of cholesterol, leading cause of heart disease; drugs are made by Sanofi, Regeneron Pharmaceuticals and Amgen.", "print_page": "1", "word_count": "1306", "_id": "5577160f798810054cfd0199", "snippet": "Early results of clinical trials raised hopes that the therapies would be critical new additions to the treatment arsenal for those at risk of heart disease, the biggest killer of Americans.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/06/10/health/cholesterol-levels-ldl-drugs-heart-attacks-fda-panel.html", "multimedia": [{"subtype": "wide", "url": "images/2015/06/10/us/DRUGS/DRUGS-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/06/10/us/DRUGS/DRUGS-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/06/10/us/DRUGS/DRUGS-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/06/10/us/DRUGS/DRUGS-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/06/10/us/DRUGS/DRUGS-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/06/10/us/DRUGS/DRUGS-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Heart", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Cholesterol", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Amgen Inc", "is_major": "Y", "rank": "4", "name": "organizations"}, {"value": "Sanofi SA", "is_major": "Y", "rank": "5", "name": "organizations"}, {"value": "Regeneron Pharmaceuticals Inc", "is_major": "Y", "rank": "6", "name": "organizations"}, {"value": "Food and Drug Administration", "is_major": "Y", "rank": "7", "name": "organizations"}, {"value": "Statins (Cholesterol-Lowering Drugs)", "is_major": "N", "rank": "8", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2015-06-10T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 3, "offset": 0, "time": 43}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}